The relationship between visceral adiposity and cardiometabolic risk in Chinese women with polycystic ovary syndrome

被引:3
|
作者
Ng, N. Y. H. [1 ]
Liu, K. H. [2 ]
Tam, C. H. T. [1 ]
Jiang, G. [1 ]
Cheng, F. [1 ]
Hou, Y. [1 ]
Yau, T. T. [1 ]
Ozaki, R. [1 ]
Chan, M. H. [3 ]
Lim, C. K. [1 ]
Sahota, D. S. [4 ]
Li, T. C. [4 ]
Cheung, L. P. [4 ]
Tam, W. H. [4 ]
Chu, W. C. W. [2 ]
Ma, R. C. W. [1 ,5 ,6 ]
机构
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China
[6] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Peoples R China
关键词
Adiposity; Visceral fat; PCOS; Insulin resistance; PREPERITONEAL FAT THICKNESS; BODY-FAT; INSULIN-RESISTANCE; OBESITY; INDEX; PCOS; ULTRASONOGRAPHY; DETERMINANT; TOPOGRAPHY; DISORDERS;
D O I
10.1016/j.orcp.2021.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare the extent to which visceral adiposity, as measured by mesenteric fat thickness, contribute to cardiometabolic risk, especially insulin resistance, in women with PCOS and healthy control. Methods: This is a cross-sectional study with a total of 190 women with PCOS fulfilling the Rotterdam diagnostic criteria. Women without PCOS were recruited from a previous study, which comprised 416 healthy women controls with normal glucose tolerance. All subjects underwent OGTT, biochemical assessment, and sonographic assessment with measurements of mesenteric, preperitoneal and subcutaneous fat thickness. Results: Mesenteric fat thickness was strongly correlated to cardiometabolic traits including blood pressure, fasting and 2-h glucose, triglycerides, HOMA-IR; and was negatively correlated to HDL-C in both cohorts (all p < 0.01). In PCOS, positive correlation was observed between mesenteric fat thickness and free androgen index (p < 0.01). Compared with controls, the regression line between mesenteric fat and HOMA-IR is much steeper in PCOS (p < 0.01). Conclusion: Women with PCOS remain more insulin resistant compared to controls at any given degree of visceral adiposity.
引用
收藏
页码:593 / 599
页数:7
相关论文
共 50 条
  • [31] Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
    Cinar, Nese
    Kizilarslanoglu, Muhammed Cemal
    Harmanci, Ayla
    Aksoy, Duygu Yazgan
    Bozdag, Gurkan
    Demir, Basaran
    Yildiz, Bulent Okan
    [J]. HUMAN REPRODUCTION, 2011, 26 (12) : 3339 - 3345
  • [32] Cardiometabolic Risk in Polycystic Ovary Syndrome Current Guidelines
    Cooney, Laura G.
    Dokras, Anuja
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2021, 50 (01) : 83 - 95
  • [33] Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome
    Vatopoulou, Anastasia
    Dionelli, Maria-Eleni
    Papanikolaou, Alexis
    Grover, Sonia
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (36) : 3808 - 3811
  • [34] The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
    Bicer, Nihan Cakir
    Ermis, Asime Aleyna
    Bas, Dilsat
    [J]. LIFE-BASEL, 2023, 13 (10):
  • [35] The cardiometabolic risk profile of middle-aged women with polycystic ovary syndrome (PCOS)
    Meun, C.
    Gunning, M.
    Louwers, Y.
    Peters, H.
    Roos-Hesselink, J.
    van Lennep, J. Roeters
    Leonel, O. Ochoa Rueda
    Ikram, A.
    Appelman, Y.
    Lambalk, N.
    Boersma, E.
    Kavousi, M.
    Fauser, B.
    Laven, J.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 454 - 454
  • [36] Suboptimal dietary intake is associated with cardiometabolic risk factors in women with polycystic ovary syndrome
    Hart, Kathryn
    Barr, Suzanne
    Reeves, Sue
    Sharp, Kay
    Jeanes, Yvonne
    [J]. NUTRITION & DIETETICS, 2016, 73 (02) : 177 - 183
  • [37] Increased risk of psychiatric disorders in Chinese women with polycystic ovary syndrome
    葛丽
    石玉华
    郝翠芳
    陈子江
    [J]. 生殖医学杂志, 2010, 19 (S2) : 8 - 14
  • [38] Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
    Robert Krysiak
    Witold Szkróbka
    Bogusław Okopień
    [J]. Pharmacological Reports, 2021, 73 : 1481 - 1481
  • [39] Visceral Adiposity Index And Cardiometabolic Risk
    Amparo, Amoroso Moya
    Marcelo, Nicolalde Cifuentes
    Herbarth, Torres Celleri
    [J]. AMERICAN HEART JOURNAL, 2020, 229 : 177 - 177
  • [40] Vascular risk in young women with polycystic ovary and polycystic ovary syndrome
    Battaglia, Cesare
    Mancini, Fulvia
    Cianciosi, Arianna
    Busacchi, Paolo
    Facchinetti, Fabio
    Marchesini, Giulio Reggiani
    Marzocchi, Rebecca
    de Aloysio, Domenico
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (02): : 385 - 395